
zzso pain is common in patients with cancer and is a significant cause of morbidity in this group of zzso 

The aim of this study was to characterize breakthrough pain in a diverse population of cancer zzso 

The study involved 1000 cancer patients from 13 European zzso Patients were screened for breakthrough pain using a recommended diagnostic zzso and then questioned about the characteristics and management of their zzso 

Of the 1000 patients, zzso reported incident pain, zzso spontaneous pain, and zzso a zzso The median number of episodes was three a zzso The median time to peak intensity was 10 minutes, with the median for patients with incident pain being five minutes zzso The median duration of zzso episodes was 60 minutes, with the median for patients with incident pain being 45 minutes zzso Eight hundred six patients stated that pain stopped them doing something, 66 that it sometimes stopped them doing something, and only 107 that it did not interfere with their zzso Patients with incident pain reported more interference with walking ability and normal work, whereas patients with spontaneous pain reported more interference with mood and zzso As well, zzso of patients could identify an intervention that improved their pain zzso zzso zzso zzso zzso zzso Regarding medications, zzso patients were receiving an zzso to treat their pain, although only 191 patients were receiving a zzso zzso product licensed for the treatment of breakthrough zzso 

zzso cancer pain is an extremely zzso zzso 

